Perceptions and experiences of nutrition interventions in individuals with amyotrophic lateral sclerosis (ALS) and their caregivers
Because injections bypass the digestive tract, they may offer different absorption characteristics than oral routes, though the clinical significance of this is still being studied
Indications: Obesity Management: Clinical trials have shown that Cagrilintide combined with GLP-1 receptor agonists (such as Semaglutide) can significantly reduce body weight, and the effect is better than single medication
However, in preclinical studies, BPC-157 has been examined in animal models involving the gut, muscles, tendons, ligaments, and nervous system
Skeletal muscle injury represents another notable application domain